Newborn screening for cystic fibrosis

Area of Science:

• Medical screening technologies
• Pediatric genetics
• Public health interventions

Background:

• Newborn screening (NBS) for cystic fibrosis (CF) has undergone substantial evolution.
• Early NBS methods were based on observational studies and evolved into mass-screening techniques in the 1970s.
• The history of CF NBS in the USA and its international applications are reviewed.

Purpose of the Study:

• To review the historical development of NBS for CF.
• To compare the utility of various CF NBS algorithms, including those from the Wisconsin trial.
• To discuss the benefits and treatment strategies associated with CF NBS.

Main Methods:

• Historical review of NBS for CF.
• Analysis of the evolution of screening methodologies and algorithms.
• Discussion of clinical benefits and treatment approaches.

Main Results:

• CF NBS has evolved from observational studies to sophisticated mass-screening programs.
• Different NBS algorithms show comparative utility in identifying CF.
• NBS for CF is associated with nutritional and respiratory health benefits.

Conclusions:

• CF NBS has a rich history of development and implementation.
• Current algorithms and early detection strategies improve outcomes for newborns with CF.
• Opportunities exist to further optimize NBS and slow CF progression through early intervention.